Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines

BACKGROUND: Previous studies indicate that the efficacy and durability of a single AbobotulinumtoxinA (ABO) treatment for moderate to severe glabellar lines may be enhanced with increasing dose, while safety outcomes remain consistent with those of the licensed dose (50 U). AIMS: Evaluation of subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Dayan, Steven, Joseph, John, Moradi, Amir, Lorenc, Z. Paul, Coleman, Kyle, Ablon, Glynis, Kaufman‐Janette, Joely, Cox, Sue Ellen, Campbell, Andrew, Munavalli, Girish, Prygova, Inna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Injectable Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322427/
https://www.ncbi.nlm.nih.gov/pubmed/35266281
http://dx.doi.org/10.1111/jocd.14906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322427/
https://www.ncbi.nlm.nih.gov/pubmed/35266281
http://dx.doi.org/10.1111/jocd.14906

Ejemplares similares